Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11208432 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL8687314 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL8686304 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL5279240 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL8685348 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL5051060 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL23403758 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL16472626 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL9635795 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL4010477 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1245414-A | Antiperspirant gel-solid stick compositions containing select nucleating agents | PROCTER & GAMBLE (US) | 2000-02-23 | — | — | CN | claimed |
| EP-0949895-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-20 | — | — | EP | claimed |
| WO-1998027939-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | claimed |
| US-12496264-B2 | Process for treating human transpiration using a cation and an anion in presence of a modulator | L'OREAL (FR) | 2025-12-16 | — | — | US | disclosed |
| EP-4267078-B1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | OREAL (FR) | 2025-12-10 | — | — | EP | disclosed |
| EP-3562558-B1 | ANHYDROUS COMPOSITION COMPRISING A MAGNESIUM SALT | OREAL (FR) | 2025-03-12 | — | — | EP | disclosed |
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240033194-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2024-02-01 | — | — | US | disclosed |
| US-11850295-B2 | Anhydrous composition comprising a magnesium salt | L'OREAL (FR) | 2023-12-26 | — | — | US | disclosed |
| EP-4267077-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2023-11-01 | — | — | EP | disclosed |
| EP-4267078-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2023-11-01 | — | — | EP | disclosed |
| WO-1998027950-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027949-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027951-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS SUBSTANTIALLY FREE OF SELECT POLAR SOLVENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027952-A1 | METHODS OF MAKING LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027953-A1 | LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027939-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| US-5750096-A | SOLID NON-POLYMERIC GELLANT BASED ON 12-HYDROXYSTEARIC ACID; ANHYDROUS LIQUID CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744130-A | COMPRISING ACTIVE MATERIAL, NONPOLYMERIC GELLANT, ANHYDROUS LIQUID CARRIER; LOW RESIDUE | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| WO-1998016196-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE PERFORMANCE OF LONG-WEARING COSMETIC PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | TRPM5, TRPM6, MSH6 | FDPS 2160/4885GGPS1 1511/4885TSHR 1959/4885 |
| US-12496264-B2 | Process for treating human transpiration using a cation and an anion in presence of a modulator | TYR, SLC26A4, SLC6A12 | FDPS 3236/4885GGPS1 3406/4885TSHR 495/4885 |
| US-11850295-B2 | Anhydrous composition comprising a magnesium salt | CUTA, TRPM5, TRPM2 | FDPS 3190/4885GGPS1 1529/4885TSHR 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.